Department of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Department of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
Infection. 2018 Apr;46(2):215-224. doi: 10.1007/s15010-017-1099-8. Epub 2017 Nov 13.
To evaluate the long-term effects of comprehensive antibiotic stewardship programs (ASPs) on antibiotic use, antimicrobial-resistant bacteria, and clinical outcomes.
Before-after study.
National university hospital with 934 beds.
Implementation in March 2010 of a comprehensive ASPs including, among other strategies, weekly prospective audit and feedback with multidisciplinary collaboration.
The primary outcome was the use of antipseudomonal antibiotics as measured by the monthly mean days of therapy per 1000 patient days each year. Secondary outcomes included overall antibiotic use and that of each antibiotic class, susceptibility of Pseudomonas aeruginosa, the proportion of patients isolated methicillin-resistant Staphylococcus aureus (MRSA) among all patients isolated S. aureus, the incidence of MRSA, and the 30-day mortality attributable to bacteremia.
The mean monthly use of antipseudomonal antibiotics significantly decreased in 2011 and after as compared with 2009. Susceptibility to levofloxacin was significantly increased from 2009 to 2016 (P = 0.01 for trend). Its susceptibility to other antibiotics remained over 84% and did not change significantly during the study period. The proportion of patients isolated MRSA and the incidence of MRSA decreased significantly from 2009 to 2016 (P < 0.001 and = 0.02 for trend, respectively). There were no significant changes in the 30-day mortality attributable to bacteremia during the study period (P = 0.57 for trend).
The comprehensive ASPs had long-term efficacy for reducing the use of the targeted broad-spectrum antibiotics, maintaining the antibiotic susceptibility of P. aeruginosa, and decreasing the prevalence of MRSA, without adversely affecting clinical outcome.
评估综合抗生素管理计划(ASPs)对抗生素使用、抗微生物耐药菌和临床结果的长期影响。
前后对照研究。
934 张床位的国立大学医院。
2010 年 3 月实施综合 ASPs,包括每周进行前瞻性审核以及多学科合作提供反馈。
主要结局指标是每年每 1000 名患者治疗日的平均每日治疗天数来衡量抗假单胞菌抗生素的使用情况。次要结局指标包括总抗生素使用情况和每种抗生素类别,铜绿假单胞菌的敏感性,金黄色葡萄球菌(S. aureus)中耐甲氧西林金黄色葡萄球菌(MRSA)分离患者的比例,MRSA 的发生率以及血源性感染导致的 30 天死亡率。
与 2009 年相比,2011 年及以后每月使用抗假单胞菌抗生素的平均值明显下降。左氧氟沙星的敏感性从 2009 年至 2016 年显著增加(趋势 P = 0.01)。其对其他抗生素的敏感性仍超过 84%,在研究期间无明显变化。MRSA 分离患者的比例和 MRSA 的发生率从 2009 年至 2016 年显著下降(趋势 P < 0.001 和 P = 0.02)。研究期间血源性感染导致的 30 天死亡率没有明显变化(趋势 P = 0.57)。
综合 ASPs 具有长期疗效,可减少目标广谱抗生素的使用,维持铜绿假单胞菌的抗生素敏感性,并降低 MRSA 的流行率,而不会对临床结果产生不利影响。